For successful reimbursement of a diagnostic test the diagnostic manufacturer must be able to understand the complexities of the current NHS system.

The UK healthcare system is primarily public, with a low private insurance coverage compared with countries such as the US. There is a wide range of different trusts and authorities delivering and impacting on healthcare and diagnostic provision.

Early assessment of reimbursement can help you decide on the most suitable path to commercialisation. Permedx and its partners have been heavily involved with reimbursement in both UK and European markets and can help you successfully navigate this often complex area.